With the month of October only barely halfway through, total medtech financings for the month have already passed $500 million. Even with several big fundings set aside as, perhaps, “exceptional”, such as the $76 million funding of LifeTech Scientific by Medtronic or the $60 million received by artificial liver company Vital Therapies, the level of funding this month is decidedly above average. Top fundings for the month include the following:
Top October 2012 Medtech Fundings (as of October 19, 2012)
Compiled by MedMarket Diligence, LLC
For the complete list of October 2012 fundings, see link.